首页> 外国专利> It is composed of 3-phenyl-4-amino-imidasol 4,5-c pyridine-2-ona and 7-phenyl-6-amino-purin-8-ona substitutes, thyroid inhibitors, especially the Burton thyroid inhibitor (Btk); compounds containing compounds; and uses for diseases such as CCER, autoimmunity, inflammation and thrombosis. (Divisional request 201703073)

It is composed of 3-phenyl-4-amino-imidasol 4,5-c pyridine-2-ona and 7-phenyl-6-amino-purin-8-ona substitutes, thyroid inhibitors, especially the Burton thyroid inhibitor (Btk); compounds containing compounds; and uses for diseases such as CCER, autoimmunity, inflammation and thrombosis. (Divisional request 201703073)

机译:它由3-苯基-4-氨基-咪唑啉[4,5-c]吡啶-2-ona和7-苯基-6-氨基嘌呤-8-ona替代物,甲状腺抑制剂,尤其是伯顿甲状腺抑制剂( Btk);含有化合物的化合物;并用于CCER,自身免疫,炎症和血栓形成等疾病。 (分项申请201703073)

摘要

N provides F amp, oacute, rmula I and / or drug salts and amperes, eacute, acceptable and effective substitutes, composici amp, oacute, n Pharma amp, eacute, understanding Utica and compounds used to treat autoimmune diseases, inflammation or C amp; Aacute. If you are already registered, please log in first.
机译:N提供F amp,急性,rmula I和/或药物盐和安培,急性,可接受和有效的替代品,composici amp,oacute,n Pharma amp,eacute,了解Utica以及用于治疗自身免疫性疾病,炎症或C amp的化合物;厉害如果您已经注册,请先登录。

著录项

  • 公开/公告号CL2019002150A1

    专利类型

  • 公开/公告日2019-11-29

    原文格式PDF

  • 申请/专利权人 PRINCIPIA BIOPHARMA INC.;

    申请/专利号CL20190002150

  • 发明设计人 GOLDSTEIN DAVID;OWENS TIMOTHY D.;

    申请日2019-07-31

  • 分类号A61K31/437;A61P35;A61P37;C07D471/04;C07D473/34;

  • 国家 CL

  • 入库时间 2022-08-21 11:18:05

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号